Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…
On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…
On Jul. 20, 2020, Oxford Immunotec announced that it had entered into a long-term agreement to supply its…
On Jul. 20, 2020, Mateon Therapeutics announced the launch of its global observational study called ARTI-19, for Artemisinin…
On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…
On Jul. 16, 2020, Dynavax Technologies and the Icahn School of Medicine at Mount Sinai announced they had…
On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…
On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…
On Jul. 15, 2020, BD (Becton, Dickinson) announced a commitment from the U.S. Department of Health and Human…
On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…
On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…
On Jul. 15, 2020, A new Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19….
On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19…
On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…
On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
On Jul. 13, 2020, 20 million masks were made available at more than 700 partner restaurant locations, including…
On Jul. 13, 2020, Tonix Pharmaceuticals announced a new preclinical research and option agreement with Kansas State University…
On Jul. 10, 2020, the Imaging Platform at the Broad Institute of MIT and Harvard, together with industry…
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
On Jul. 9, 2020 Moderna and Laboratorios Farmaceuticos Rovi announced a collaboration for large-scale, commercial fill-finish manufacturing of…
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
On Jul. 8, 2020, scientists at the UC Berkeley-UCSF Joint Medical Program reported that for some individuals with…
On Jul. 8, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
On Jul. 8, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that it had created a registry…
On Jul. 8, 2020, the Mount Sinai Health System, Emergent BioSolutions and ImmunoTek Bio Centers announced a collaboration…
On Jul. 8, 2020, Gilead Sciences announced data evaluating the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP…
On Jul. 8, 2020, Moderna announced that it had completed enrollment for both cohorts of the Phase 2…
On Jul. 8, 2020, Constant Therapeutics reported that its peptide drug TXA127 was tested in a series of…
On Jul. 8, 2020, BD (Becton, Dickinson) announced the formation of a strategic, public-private partnership with the Biomedical…